by Absci
Absci's Integrated Drug Creation platform uses generative AI and a wet lab to design biologics such as antibodies. Absci uses it for its own pipeline and partner programs.
Web appContact for pricing
Step 1: Contact Absci through the partner page.
Step 2: Define the target.
Step 3: Absci generates data and trains models.
Step 4: AI designs candidates.
Step 5: The wet lab validates them.
Biologics, such as antibodies, against difficult-to-drug targets.
The company says as little as six weeks from AI design to validated candidate.
An antibody targeting the prolactin receptor, designed for androgenetic alopecia.
Leaders across pharma, tech and academia.
Insilico Medicine Pharma.AIPharma.ai is Insilico Medicine's set of generative AI software for drug discovery, scientific research and longevity. It covers target discovery, molecule generation, trial design and research agents.